Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
No Data
Amplia Therapeutics Adds 240,385 New Shares to ASX Listing
Amplia Therapeutics Shares Up After Entering Agreement to Conduct Ovarian Cancer Clinical Study
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
Amplia Advances Narmafotinib Program With Strong Pancreatic Cancer Data and Phase 3 Readiness Steps
Accent Trial Mature Data Presented at International Conference
Amplia Therapeutics Says No Toxicity Concerns Identified Regarding Narmafotinib Drug Candidate After Recruitment Halt in Clinical Trial